These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6044410)

  • 21. [Regulation of a portacaval anastomosis with an implanted valve animated by a magnetic source].
    Marion P; Lapeyre D; de Bennetot M; Cottin M; Estanove S; George M; Rubet A; Pinet F
    Lyon Chir; 1971; 67(5):383-5. PubMed ID: 5161061
    [No Abstract]   [Full Text] [Related]  

  • 22. [Apropos of a case of the "Cruveilhier-Baumgarter syndrome"; omphalo-caval anastomosis].
    Mansouri H; Rahmouni D; Bendali S; Benabadji R
    J Chir (Paris); 1968 Sep; 96(3):207-14. PubMed ID: 5727216
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.
    Zsigmond GL; Bodnár A; Karácsonyi S
    Acta Chir Hung; 1984; 25(2):97-106. PubMed ID: 6464621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Functional activity of the cirrhotic liver before and after latero-lateral portacaval anastomosis].
    Bucciarelli G; Bechi P; Masi C; Giannini G
    Minerva Med; 1980 Mar; 71(9):693-7. PubMed ID: 7360407
    [No Abstract]   [Full Text] [Related]  

  • 25. [Portacaval anastomosis for intractable cirrhotic ascites. A study in 18 patients (author's transl)].
    Huguet C; Hannoun L; Opolon P; Lévy VG
    Gastroenterol Clin Biol; 1981 Mar; 5(3):324-31. PubMed ID: 7227738
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood glucose and glucoregulatory hormones in liver cirrhosis: a study of 24 hour profiles and of the role of portal-systemic shunting].
    Marchesini G; Zoli M; Dondi C; Angiolini A; Forlani G; Melli A; Bianchi FB; Pisi E
    Gastroenterol Clin Biol; 1982 Mar; 6(3):272-8. PubMed ID: 7047286
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation.
    Merli M; Leonetti F; Riggio O; Valeriano V; Ribaudo MC; Strati F; Tisone G; Casciani CU; Capocaccia L
    Hepatology; 1999 Sep; 30(3):649-54. PubMed ID: 10462370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic neuropathy. A clinical and electrophysiological study.
    Kardel T; Nielsen VK
    Acta Neurol Scand; 1974; 50(4):513-26. PubMed ID: 4852249
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

  • 30. Remission of psoriatic arthritis after porto-caval anastomosis in a patient with primary biliary cirrhosis.
    D'Amico E; Palazzi C; Capani F
    J Rheumatol; 1999 Jan; 26(1):236. PubMed ID: 9918274
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatopexy using tissue adhesives as a complementary procedure of termino-lateral portacaval anastomosis in the treatment of ascites. (Immediate and remote results in 33 operated cases)].
    Belli L; Forti D
    J Chir (Paris); 1966 Dec; 92(6):589-606. PubMed ID: 5973359
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endovascular intrahepatic portacaval shunting].
    Borisov AE; Ryzhkov VK; Karev AV; Kashchenko VA; Vasiukova EA
    Khirurgiia (Mosk); 2002; (6):34-7. PubMed ID: 12109183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the urinary secretagogue power (U.S.P.) after portacaval anastomosis].
    Bonfils S; Bader JP; Leger L; Boury G; Bernades P; Dubrasquet M
    Presse Med (1893); 1967 Nov; 75(47):2395-6. PubMed ID: 6060313
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated plasma glucagon levels in cirrhosis of the liver.
    Marco J; Diego J; Villanueva ML; Diaz-Fierros M; Valverde I; Segovia JM
    N Engl J Med; 1973 Nov; 289(21):1107-11. PubMed ID: 4754949
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in carbohydrate metabolism in hepatic cirrhosis. IV. Resistance to the effect of insulin].
    Santolaria Fernández F; González Garciá C; González Reimers E; Burgos Ojeda A; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Apr; 63(4):349-56. PubMed ID: 6348895
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood glucose and insulin curves in postgastrectomy syndrome associated with liver cirrhosis].
    Smoczyński M; Michalik T
    Wiad Lek; 1974 Sep; 27(16):1509-12. PubMed ID: 4408682
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sulfobromophthalein clearance and survival of cirrhotics after an elective porto-systemic shunt].
    Spina GP; Galeotti F; Sorato R; Maffei-Faccioli A; Zotti S; Ghidini O
    Minerva Chir; 1980 Feb; 35(3):135-42. PubMed ID: 7374971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral hemodynamics and metabolism in hepatic cirrhosis. Effects of portacaval shunt operation.
    Bianchi Porro G; Maiolo AT
    Digestion; 1970; 3(2):111-21. PubMed ID: 5423315
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective randomized trial of the selective distal splenorenal shunt.
    Langer B; Rotstein LE; Stone RM; Taylor BR; Patel SC; Blendis LM; Colapinto RF
    Surg Gynecol Obstet; 1980 Jan; 150(1):45-8. PubMed ID: 6965330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.